Citation: H. Gharib et El. Mazzaferri, THYROXINE SUPPRESSIVE THERAPY IN PATIENTS WITH NODULAR THYROID-DISEASE, Annals of internal medicine, 128(5), 1998, pp. 386-394
Citation: H. Gharib, CHANGING CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF THYROID-NODULES, Endocrinology and metabolism clinics of North America, 26(4), 1997, pp. 777
Authors:
HESHMATI HM
GHARIB H
KHOSLA S
ABULEBDEH HS
LINDOR NM
THIBODEAU SN
Citation: Hm. Heshmati et al., GENETIC TESTING IN MEDULLARY-THYROID CARCINOMA SYNDROMES - MUTATION TYPES AND CLINICAL-SIGNIFICANCE, Mayo Clinic proceedings, 72(5), 1997, pp. 430-436
Authors:
SCHLINKERT RT
VANHEERDEN JA
GOELLNER JR
GHARIB H
SMITH SL
ROSALES RF
WEAVER AL
Citation: Rt. Schlinkert et al., FACTORS THAT PREDICT MALIGNANT THYROID LESIONS WHEN FINE-NEEDLE ASPIRATION IS SUSPICIOUS FOR FOLLICULAR NEOPLASM, Mayo Clinic proceedings, 72(10), 1997, pp. 913-916
Citation: Gh. Tan et H. Gharib, THYROID NODULAR DISEASE - DIAGNOSTIC EVALUATION AND MANAGEMENT - REPLY, Archives of internal medicine, 157(5), 1997, pp. 575-575
Citation: Gh. Tan et H. Gharib, THYROID INCIDENTALOMAS - MANAGEMENT APPROACHES TO NONPALPABLE NODULESDISCOVERED INCIDENTALLY ON THYROID IMAGING, Annals of internal medicine, 126(3), 1997, pp. 226-231
Authors:
HESHMATI HM
COHEN R
MODIGLIANI E
GHARIB H
PERRET G
BATTESTI JP
ORGIAZZI J
Citation: Hm. Heshmati et al., HYPOTHYROIDISM DUE TO THYROTROPIN-RECEPTOR BLOCKING ANTIBODIES ASSOCIATED WITH SARCOIDOSIS, Annales de medecine interne, 148(1), 1997, pp. 102-103
Authors:
HESHMATI HM
GHARIB H
VANHEERDEN JA
SIZEMORE GW
Citation: Hm. Heshmati et al., ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS AND MANAGEMENT OF MEDULLARY-THYROID CARCINOMA, The American journal of medicine, 103(1), 1997, pp. 60-69
Authors:
ENG C
CLAYTON D
SCHUFFENECKER I
LENOIR G
COTE G
GAGEL RF
VANAMSTEL HKP
LIPS CJM
NISHISHO I
TAKAI SI
MARSH DJ
ROBINSON BG
FRANKRAUE K
RAUE F
XUE FY
NOLL WW
ROMEI C
PACINI F
FINK M
NIEDERLE B
ZEDENIUS J
NORDENSKJOLD M
KOMMINOTH P
HENDY GN
GHARIB H
THIBODEAU SN
LACROIX A
FRILLING A
PONDER BAJ
MULLIGAN LM
Citation: C. Eng et al., THE RELATIONSHIP BETWEEN SPECIFIC RET PROTOONCOGENE MUTATIONS AND DISEASE PHENOTYPE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - INTERNATIONAL RET MUTATION CONSORTIUM ANALYSIS, JAMA, the journal of the American Medical Association, 276(19), 1996, pp. 1575-1579
Authors:
KANE LA
TSAI MS
GHARIB H
KHOSLA S
ROBERTSON DM
SCHAID DJ
HONCHEL R
THIBODEAU SN
Citation: La. Kane et al., FAMILIAL MEDULLARY-THYROID CANCER AND PROMINENT CORNEAL NERVES - CLINICAL AND GENETIC-ANALYSIS, The Journal of clinical endocrinology and metabolism, 80(1), 1995, pp. 289-293
Authors:
ORIORDAN DS
OBRIEN T
GHARIB H
GRANT CS
VANHEERDEN JA
Citation: Ds. Oriordan et al., ENDOCRINE AND EXTRAENDOCRINE FEATURES OF MULTIPLE ENDOCRINE NEOPLASIATYPE 2B, British Journal of Surgery, 82(10), 1995, pp. 1430-1430
Citation: Gh. Tan et al., SOLITARY THYROID-NODULE - COMPARISON BETWEEN PALPATION AND ULTRASONOGRAPHY, Archives of internal medicine, 155(22), 1995, pp. 2418-2423